Immunotherapies Provide Promising Results in Advanced Gastric Cancer
Immunotherapies have been tested in melanoma, breast, prostate, kidney, and lung cancers, and are now being studied in advanced gastric cancers.
Immunohistochemistry Effectively Detects ROS1-Positive NSCLC
Immunohistochemistry can effectively be used for the identification of ROS1 gene alterations to ascertain eligibility for the targeted therapy crizotinib for patients with non-small cell lung cancer.
2 Commerce Drive Cranbury, NJ 08512